Cargando…
Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860160/ https://www.ncbi.nlm.nih.gov/pubmed/33542181 http://dx.doi.org/10.1038/s41392-021-00468-9 |
| _version_ | 1783646883563962368 |
|---|---|
| author | Bai, Yu Ye, Fei Feng, Yong Liao, Hanyi Song, Hao Qi, Jianxun Gao, George Fu Tan, Wenjie Fu, Lifeng Shi, Yi |
| author_facet | Bai, Yu Ye, Fei Feng, Yong Liao, Hanyi Song, Hao Qi, Jianxun Gao, George Fu Tan, Wenjie Fu, Lifeng Shi, Yi |
| author_sort | Bai, Yu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7860160 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78601602021-02-04 Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir Bai, Yu Ye, Fei Feng, Yong Liao, Hanyi Song, Hao Qi, Jianxun Gao, George Fu Tan, Wenjie Fu, Lifeng Shi, Yi Signal Transduct Target Ther Letter Nature Publishing Group UK 2021-02-04 /pmc/articles/PMC7860160/ /pubmed/33542181 http://dx.doi.org/10.1038/s41392-021-00468-9 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter Bai, Yu Ye, Fei Feng, Yong Liao, Hanyi Song, Hao Qi, Jianxun Gao, George Fu Tan, Wenjie Fu, Lifeng Shi, Yi Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir |
| title | Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir |
| title_full | Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir |
| title_fullStr | Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir |
| title_full_unstemmed | Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir |
| title_short | Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir |
| title_sort | structural basis for the inhibition of the sars-cov-2 main protease by the anti-hcv drug narlaprevir |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860160/ https://www.ncbi.nlm.nih.gov/pubmed/33542181 http://dx.doi.org/10.1038/s41392-021-00468-9 |
| work_keys_str_mv | AT baiyu structuralbasisfortheinhibitionofthesarscov2mainproteasebytheantihcvdrugnarlaprevir AT yefei structuralbasisfortheinhibitionofthesarscov2mainproteasebytheantihcvdrugnarlaprevir AT fengyong structuralbasisfortheinhibitionofthesarscov2mainproteasebytheantihcvdrugnarlaprevir AT liaohanyi structuralbasisfortheinhibitionofthesarscov2mainproteasebytheantihcvdrugnarlaprevir AT songhao structuralbasisfortheinhibitionofthesarscov2mainproteasebytheantihcvdrugnarlaprevir AT qijianxun structuralbasisfortheinhibitionofthesarscov2mainproteasebytheantihcvdrugnarlaprevir AT gaogeorgefu structuralbasisfortheinhibitionofthesarscov2mainproteasebytheantihcvdrugnarlaprevir AT tanwenjie structuralbasisfortheinhibitionofthesarscov2mainproteasebytheantihcvdrugnarlaprevir AT fulifeng structuralbasisfortheinhibitionofthesarscov2mainproteasebytheantihcvdrugnarlaprevir AT shiyi structuralbasisfortheinhibitionofthesarscov2mainproteasebytheantihcvdrugnarlaprevir |